Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Dilemma of Neonatal Circumcision in Egypt

NCT07076992 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-07-22
Last updated
2025-07-23

Condition(s) studied

NeonateCircumcision

Investigational drug(s) / intervention(s)

Circumcision by PlastibellCircumcision by Gomco

Circumcision by Plastibell: Patients will undergo circumcision by Plastibell (PB).

Circumcision by Gomco: Patients will undergo circumcision by the Gomco (GM).

Study summary

The study aims to compare wound healing, wound healing complications, cosmetic outcome, and level of parental satisfaction amongst four techniques of neonatal circumcision.

Eligibility

Sex
MALE
Min age
—
Max age
3 Months
Healthy volunteers
No
Inclusion Criteria: * Male infants less than 3 months old. * Undergoing circumcision. Exclusion Criteria: * Male infants more than 3 months old. * Infants with bleeding disorders. * Neonates with hypospadias, epispadias, micropenis, disorders of sex development (DSD) * Neonates with buried or webbed penis.

Primary outcome measure(s)

  • Post circumcision bleeding — 2 hours postoperatively
    All infants will be followed up for 2 hours for early detection and management of post circumcision bleeding.

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta El-Gharbia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07076992 on ClinicalTrials.gov ↗ ← All trials in Egypt